Lin, R., Kim, S. J., Bromberg, M., Shouval, R., Hogan, M., Parascondola, A., Saldia, A., Pavkovic, E., Geva, M., Gomez-Llobell, M., Escribano-Serrat, S., Einarsdottir, S., Palomba, L., Dahi, P., Scordo, M., Shah, G., Boardman, A., Falchi, L., Lue, J., Salles, G., Sauter, C., Park, J., Perales, M., Hamlin, P., Shahrokni, A., Gönen, M., Giralt, S. (2025). Pre-existing cognitive impairment is associated with reduced long-term survival following chimeric antigen receptor T-cell therapy for non-Hodgkin's lymphoma. Blood. https://doi.org/10.1182/blood-2025-6296